- Report
- December 2023
- 150 Pages
Global
From €4078EUR$4,250USD£3,512GBP
- Report
- August 2023
- 145 Pages
Global
From €3022EUR$3,150USD£2,603GBP
- Directory
- May 2024
Global
- Webinar
- March 2024
- 90 Minutes
United States
From €352EUR$367USD£303GBP
- Report
- March 2020
- 48 Pages
Global
From €947EUR$988USD£816GBP
€1895EUR$1,975USD£1,632GBP
- Report
- July 2022
- 100 Pages
Global
From €2639EUR$2,750USD£2,273GBP
- Report
- April 2023
- 119 Pages
Global
From €4318EUR$4,500USD£3,719GBP
- Webinar
- February 2023
- 90 Minutes
United States
- Report
- May 2022
- 196 Pages
Global
From €2874EUR$2,995USD£2,475GBP
- Book
- January 2020
- 378 Pages
- Book
- June 2014
- 600 Pages
- Book
- September 2009
- 600 Pages
The Investigational Device Exemption (IDE) market is a subset of the medical device industry. It refers to the process of obtaining approval from the U.S. Food and Drug Administration (FDA) to conduct clinical trials of medical devices. The IDE process is designed to ensure that the safety and effectiveness of the device is established before it is made available to the public. The IDE process involves submitting an application to the FDA, which includes information about the device, the proposed clinical trial, and the safety and efficacy data. Once approved, the device can be used in clinical trials.
Companies in the IDE market include Abbott, Boston Scientific, Medtronic, Stryker, Johnson & Johnson, and Philips. Show Less Read more